Astrelis
Dialysis facility · PA

DIALYSIS 392535

CCN 392535Latest FY 2024
Historical record. CMS lists this CCN as terminated (voluntary - merger/closure). No successor CCN is recorded. The financials below are the historical results reported under this number and are excluded from current peer comparisons and state counts.
Cost-report basis
HCRIS · as filed
Not audited by Astrelis

Operating margin: -5.9% in FY2024. Days cash on hand: 366 days in FY2024. Total operating revenue: $0.9M in FY2024. Total margin (including nonoperating): -5.4% in FY2024. Figures as filed; not audited by Astrelis.

Financial anchor year: FY24. Margin and revenue are as filed for FY24. Balance-sheet measures (current ratio, equity financing, days in A/R) use FY23, the latest filing whose balance sheet reconciled as filed. Every tile below states its own fiscal year; nothing is carried forward or estimated.
The read

A dialysis facility in PA. It ran an operating loss of 5.9% in FY24 on $0.9M of operating revenue. It held 366 days of cash on hand. Operating margin declined from -1.2% in FY20 to -5.9% in FY24, though it rose 4.5 points in the most recent year.

Operating margin · FY24
-5.9%
Astrelis calculation · as-filed inputs
▲ 4.5 pts vs FY23
not ranked: no valid same-year pool for this metric (needs n ≥ 25 and ≥ 50% of the cohort's filers at FY24)
Days cash on hand · FY24
366d
all sources
Astrelis calculation · as-filed inputs
▲ 9 days vs FY23
not ranked: no valid same-year pool for this metric (needs n ≥ 25 and ≥ 50% of the cohort's filers at FY24)
Total operating revenue · FY24
$0.9M
Astrelis calculation · as-filed inputs
▼ $0.4M vs FY23
not ranked: no valid same-year pool for this metric (needs n ≥ 25 and ≥ 50% of the cohort's filers at FY24)
Total margin · incl. nonoperating · FY24
-5.4%
Astrelis calculation · as-filed inputs
▲ 4.3 pts vs FY23
not ranked: no valid same-year pool for this metric (needs n ≥ 25 and ≥ 50% of the cohort's filers at FY24)

The money

$ thousands · HCRIS cost-report basis · as filed, QA-gated

Ratios tell you how this dialysis facility is doing. Statements tell you what kind of organization it is, and where the money comes from. Every figure below traces to a public cost-report filing, shown as filed. A ratio computes only when every input is reported in the filing (otherwise its cell states which input is Not reported in source); a year whose balance sheet does not reconcile is labeled, and its derived ratios read Astrelis calculation unavailable. Not audited by Astrelis.

Operating margin
-5.9% (FY24)
Operating income ÷ total operating revenue
Astrelis calculation · HCRIS WS G-3
Total margin
-5.4% (FY24)
Net income ÷ total revenue incl. nonoperating
Astrelis calculation · HCRIS WS G-3
Days cash on hand
366d (FY24)
Cash & investments ÷ daily operating expense
Astrelis calculation · HCRIS WS G / G-3
Current ratio
17.86× (FY23)
Total current assets ÷ current liabilities
Astrelis calculation · HCRIS WS G
Equity financing ratio
96% (FY23)
Total net assets ÷ total assets
Astrelis calculation · HCRIS WS G
Days in net patient A/R
45d (FY23)
Net patient receivables ÷ (net patient revenue ÷ 365), same fiscal year
Astrelis calculation · HCRIS WS G / G-3
$ in thousands
Line itemFY22FY23FY24 · 230 days
Patient revenue1,0991,245857
Total operating revenue1,0991,245857
Total operating expenses1,2831,374908
Operating income(183)(129)(51)
Operating margin %-16.7%-10.4%-5.9%
Other non-operating, net1774
Net income(166)(122)(47)
Net income %-14.9%-9.7%-5.4%
— = Not reported in source for that year.
HCRIS CMS-265 cost report · $ thousands · FY20–FY24 · operating revenue reflects net patient service revenue · FY20–21 may include COVID-era relief funding

How it operates

quality & operational context · CMS public reporting

The metrics this dialysis facility type is judged on: care quality, patient experience, and scale. Each is labeled by provenance class and public source; descriptive context only, never a ranking or adequacy claim. Provenance labels: Reported value is copied from the named public source; Astrelis calculation is a formula applied to unchanged reported inputs, with the formula shown; Illustrative estimate is a benchmark gap, multiplier, or scenario — never a measurement.

Total treatments
2,316
Reported value2024
HCRIS CMS-265
Cost per treatment ($)
391.92
Astrelis calculation2024
HCRIS CMS-265
Net revenue per treatment ($)
370.08
Astrelis calculation2024
HCRIS CMS-265

Trajectory

Cost-report basis · 5 reporting years
Operating margin
-1.2%+9.5%-16.7%-10.4%-5.9%FY20FY21FY22FY23FY24
Days cash on hand
441 days574 days401 days357 days366 daysFY20FY21FY22FY23FY24

State context

Pennsylvania
County-level statistics: linkage not established — this record's county mapping is not verified in the resolved spine, and we never place a facility in a county by guesswork. State-level context appears here once a state aggregate layer lands.
Operating margin (as filed)FY24Astrelis calculation

-5.9% operating margin in FY24.

The Board Briefing

Operating margin improved 4.5 points vs FY23 — the briefing traces why, line by line.

Reserve The Board Briefing →
Report coverage: Historical Facility Benchmark. 7 of 10 facility measures available from public sources. This CCN is terminated. The report benchmarks the record's final filed years against their own contemporaneous peer pools and says so on every exhibit; no current-year comparison is implied. The refund guarantee stands: if we cannot deliver the published scope, you pay nothing.

Portfolio Performance Review

A roster-priced triage of the per-facility benchmarks: every facility on your roster, benchmarked and sorted. Requires only a CCN roster.

From $7,500Founding Edition · built to order, first edition · priced by roster size · invoice after coverage confirmation · within 30 days
Request: scoped and quoted before any invoice. No payment is collected on this site.

Cite this page

release 2321a4fc37a7 · 2026-10-22

Astrelis Atlas, "Dialysis 392535", https://astrelis.co/providers/dialysis/392535, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Machine-readable twin of this page: astrelis.co/providers/dialysis/392535.md (Markdown, the same figures with their fiscal years, pools and definitions). Last modified: release 2321a4fc37a7, 2026-10-22. Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.

build 2321a4fc37a7 · 2026-10-22 · dev